1. Trang chủ
  2. » Luận Văn - Báo Cáo

Báo cáo khóa học: Membrane transport of fatty acylcarnitine and free L-carnitine by rat liver microsomes pot

8 379 1
Tài liệu đã được kiểm tra trùng lặp

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 8
Dung lượng 361,62 KB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

Membrane transport of fatty acylcarnitine and free L -carnitineby rat liver microsomes Jason M.. Liver microsomal vesicles that were shown to be at least 95% impermeable to palmitoyl-CoA

Trang 1

Membrane transport of fatty acylcarnitine and free L -carnitine

by rat liver microsomes

Jason M Gooding, Majid Shayeghi and E David Saggerson

Department of Biochemistry and Molecular Biology, University College London, UK

Recent studies have suggested that parts of the hepatic

activities of diacylglycerol acyltransferase and acyl

choles-terol acyltransferase are expressed in the lumen of the

endoplasmic reticulum (ER) However the ER membrane is

impermeable to the long-chain fatty acyl-CoA substrates of

these enzymes Liver microsomal vesicles that were shown to

be at least 95% impermeable to palmitoyl-CoA were used to

demonstrate the membrane transport of palmitoylcarnitine

and freeL-carnitine – processes that are necessary for an

indirect route of provision of ER luminal fatty acyl-CoA

through a luminal carnitine acyltransferase (CAT)

Experi-mental conditions and precautions were established to

per-mit measurement of the transport of [14C]palmitoylcarnitine

into microsomes through the use of the luminal CAT and

acyl-CoA:ethanol acyltransferase as a reporter system to

detect formation of luminal [14C]palmitoyl-CoA Rapid, unidirectional transport of free L-[3H]carnitine by micro-somes was measured directly This process, mediated either

by a channel or a carrier, was inhibited by mersalyl but not by N-ethylmaleimide or sulfobetaine – properties that differentiate it from the mitochondrial inner membrane carnitine/acylcarnitine exchange carrier These findings are relevant to the understanding of processes for the reassembly

of triacylglycerols that lipidate very low density lipoprotein particles as part of a hepatic triacylglycerol lipolysis/ re-esterification cycle

Keywords: acylcarnitine; carnitine; microsomes; liver; trans-port

Although mammalian intracellular membranes are

imper-meable to the Coenzyme A thioesters of long-chain fatty

acids, these activated derivatives, which are synthesized

from nonesterified fatty acids by fatty acyl-CoA synthetase

on the cytosolic aspect of organelle membranes, are the

substrates for metabolic processes within at least three

cellular organelles In mitochondria, it is well established

that CPT1, a carnitine acyltransferase associated with the

outer membrane, generates fatty acylcarnitine derivatives

which can then traverse the inner membrane via a

carnitine/acylcarnitine exchange carrier (CAC) Within

the mitochondrial interior, the latent carnitine

acyltrans-ferase CPT2then facilitates the re-formation of fatty

acyl-CoAs which are then substrates for b-oxidation within the

mitochondrial matrix [1] Fatty acyl-CoAs are also

sub-strates for chain-shortening by b-oxidation within the

matrix of peroxisomes As peroxisomes also contain overt and latent carnitine acyltransferase activities [2,3] and express the CAC protein [4], it has been concluded that activated fatty acids access the peroxisomal matrix through

a system that is closely analogous to the mitochondrial one Enzymes within the lumen of the endoplasmic reticulum (ER) also require fatty acyl-CoA thioesters as substrate

A latent form of diacylglycerol acyltransferase (DGAT), assigned to the luminal surface of the ER membrane and which can be differentiated from a cytosolically oriented DGAT, has been described [5–7] This latent DGAT may

be involved in the reassembly of triacylglycerols which lipidate very low density lipoprotein (VLDL) particles as part of a hepatic triacylglycerol lipolysis/re-esterification cycle [2,3,8–12] Two forms of acyl cholesterol acyltrans-ferase (ACAT) are also known and one of these is suggested

to be oriented from the ER membrane towards the lumen and to contribute to provision of cholesteryl esters for lipidation of VLDL particles [13–16] Finally, acyl-CoA:eth-anol acyltransferase (AEAT) is an enzyme activity

appears to be exclusively localized to the ER lumen [17]

As they do not readily penetrate the ER membrane [17], it has been proposed that the fatty acyl-CoA substrates for luminal enzymes such as DGAT, ACAT and AEAT are generated by a malonyl-CoA-insensitive carnitine acyltransferase (CAT) that is localized in the ER lumen [18,19] It has been envisaged that the substrate for this luminal CAT is fatty acylcarnitine, which is trans-ported from the cytosol to the ER lumen [2,3,12] (Fig 1) and which is generated by CPT1 located at sites distinct from the ER [20] or also by an ER-targeted form of CPT [12,21–23] For the luminal CAT to function in the

Correspondence to E D Saggerson, Department of Biochemistry

and Molecular Biology, University College London,

Gower Street, London, WC1E 6BT, UK.

Fax: + 44 20 76797193, Tel.: + 44 20 76797320,

E-mail: Saggerson@biochem.ucl.ac.uk

Abbreviations: ACAT, acyl cholesterol acyltransferase; AEAT,

acyl-CoA:ethanol acyltransferase; CAC, carnitine/acylcarnitine exchange

carrier; CAT, carnitine acyltransferase; CPT 1 , the overt carnitine

palmitoyltransferase of mitochondria; DGAT, diacylglycerol

acyltransferase; ER, endoplasmic reticulum; etomoxir,

2-[6-(4-chlorophenoxy)hexyl]oxirane carboxylic acid; [(Np-O) 2 P i ],

bis-(4-nitrophenyl)phosphate; VLDL, very low density lipoprotein.

(Received 20 October 2003, revised 8 January 2004,

accepted 16 January 2004)

Trang 2

way envisaged in Fig 1 there must additionally be a

means whereby the L-carnitine product can escape from

the ER and there must be a supply of ER luminal free

CoASH The CAC protein is not expressed at detectable

levels in liver microsomes [4], so at present it is not clear

how inward and outward transport of fatty acylcarnitine

andL-carnitine, respectively, across the ER membrane are

facilitated In the present study, we report direct evidence

for the passage of radiolabelledL-carnitine across

micro-somal membranes We also report on studies of the

uptake of [14C]palmitoylcarnitine into the lumen of

sealed microsomal vesicles Direct measurement of this

is technically very difficult or impossible as these lipid

substrates bind nonspecifically to membrane proteins and

lipids Therefore indirect approaches using reporter

systems must be used Broadway et al [12] used the

ER luminal coupled system of CAT and AEAT as a

reporter in preliminary studies to show that sealed liver

microsomes could generate ethyl palmitate from

palmi-toylcarnitine provided exogenous free CoASH was

pre-sent, and concluded that these findings were consistent

with a trans-ER membrane transport of

palmitoylcarni-tine together with an ER transport process for CoASH,

the cosubstrate for microsomal CAT [12] In support of

the notion of fatty acylcarnitine transport in the ER,

Abo-Hashema et al [24] used the latent DGAT activity as

a reporter system to demonstrate a carnitine-dependent

conversion of oleoyl-CoA into luminal triacylglycerol

In those experiments, microsomes were fused with

liposomes encapsulating a supply of CoASH for the

luminal CAT In the present study, we have re-evaluated

and further developed the experimental approach of

Broadway et al [12] through the use of

bis-(4-nitrophe-nyl)phosphate [(Np-O)2Pi] which is used to decrease

interference from carboxyesterase and thioesterase

activ-ities in microsomes [25] From these studies, we confirm

the presence of a system that facilitates the entry of

palmitoylcarnitine into sealed microsomes but discount

the previous notion of a concomitant transport system for

CoASH [12]

Materials and methods Chemicals

Routinely used chemicals were from BDH Ltd (Poole, Dorset, UK) or from Sigma Chemical Co Ltd (Poole, Dorset, UK) The sodium salt of etomoxir{2-[6-(4-chloro-phenoxy)hexyl]oxirane carboxylic acid} was from

H P O Wolf, (Projekt-Entwicklung GmbH, Allensbach, Germany) [3H]Carnitine, [14C]inulin, [14 C]palmitoylcarni-tine and [14C]palmitoyl-CoA were from Amersham Inter-national (Little Chalfont, Bucks, UK) The radiolabelled palmitoylcarnitine was supplied in a 50 : 50 (v/v) water/ ethanol solution which was removed by evaporation in

a stream of nitrogen before use This ensured that no ethanol was present in ethanol-independent acylation assays Ethyl[14C]palmitate was synthesized as described

by Diczfalusy et al [25]

Isolation of microsomes from rat liver 2,3Fed male Sprague–Dawley rats (180–220 g) were killed

an approved schedule/method [schedule/method approved

by the UK Home Office under the Act of Parliament Animals (Scientific Procedures) Act 1986 and the local UCL Animal Experimentation Ethics Committee] Livers were immedi-ately removed and washed in ice-cold isolation medium (5 mMTris/HCl buffer, pH 7.4, containing 220 mM mann-itol, 80 mM sucrose, 1 mM EDTA, 5 lgÆmL)1 bestatin,

5 lgÆmL)1 leupeptin and 1 mM phenylmethanesulfonyl fluoride) and then homogenized in 4 vols of the same buffer with four strokes of a motor-driven Potter-type homogeniser The homogenate was centrifuged at 500 g for

10 min; the supernatant was then centrifuged at 10 000 g for 20 min followed by centrifugation of the 10 000 g super-natant at 20 000 g for 20 min The resulting 20 000 g supernatant was then ultra-centrifuged at 100 000 g for

60 min The pellet was resuspended in fresh isolation medium and recentrifuged at 100 000 g for 60 min The microsomal pellet was then resuspended (80–100 mgÆmL)1) and stored at)70 °C as 100 lL aliquots in HS buffer (5 mM

Hepes buffer, pH 7.4 containing 250 mM sucrose) The specific activity of cytocrome c oxidase (a mitochondrial inner membrane marker) was less than 1% of that found in mitochondrial fractions (results not shown) Similar micro-somal fractions have previously been shown to contain very little activity of monoamine oxidase (a mitochondrial outer membrane marker) [19]

In some instances 4 mMCoASH with 4 mM dithiothre-itol were included in isolation medium and in HS buffer Microsomal vesicles described as sealed were obtained by thawing stored aliquots and suspending at the required concentration in HS buffer

The intactness of microsomal preparations was routinely assessed by the latency of mannose 6-phosphatase [26] which exceeded 90% Further evidence of the intactness of micro-somal vesicles was obtained from measurements of AEAT activity (see below) Microsomal vesicles described as

permeabilised were similarly suspended in HS buffer to which the pore-forming antibiotic alamethicin [27–29] had been added from a stock solution of 20 mgÆmL)1dissolved in dimethyl sulfoxide At the concentration used (15 lgÆmL)1)

Fig 1 A scheme summarizing processes to provide the fatty acyl-CoA

substrate for AEAT,DGAT and ACAT in the ER lumen.

Trang 3

we found that alamethicin abolished latency of mannose

6-phosphatase essentially immediately (results not shown)

Treatment of microsomes with etomoxir

Microsomes were diluted to approximately 10 mgÆmL)1in

HS buffer containing 5 mM ATP, 10 mM MgCl2, 2 mM

CoASH, 50 lM sodium etomoxir and BSA (1 mgÆmL)1)

and incubated at 25°C for 30 min followed by addition of

4 vols of ice-cold HS buffer The diluted microsomes were

then centrifuged at 200 000 g for 30 min, resuspended in HS

buffer (approximately 50 mgÆmL)1) and stored at)70 °C

Assay of ethanol-dependent and -independent

acyltransferase activities

Assays were performed either with sealed microsomes or in

the permeabilized state (with alamethicin [15 lgÆmL)1]) at

30°C in a final volume of 1.4 mL in 10 mMTris/HCl buffer

(pH 7.4) containing 300 mM sucrose, 10 mM MgCl2,

0.8 mM EDTA, bovine albumin (1 mgÆmL)1) and 40 lM

[14C]palmitoyl-CoA (1.8 lCiÆlmol)1) with or without 10 lL

of ethanol (123 mMfinal concentration) Where indicated,

250 lM(Np-O)2Pi[25] was included in assays Assays were

initiated by the addition of 700 lg of microsomal protein

At zero, 1, 2, 5, 10, 15 and 20 min 200 lL samples of

the assay mixture were removed and mixed with 1.5 mL

propan-2-ol/heptane/water (80 : 20 : 2; v/v/v) After mixing

with a further 1 mL of heptane and 0.5 mL of water the

upper (heptane) layer was removed and washed with 2 mL

of 50 mMNaOH dissolved in 50% (v/v) ethanol Washed

heptane layer (650 lL) was taken for liquid scintillation

counting AEAT (ethanol-dependent) activity was

calcula-ted by subtracting 14C-labelled product formation in the

absence of ethanol from that in its presence Measurement

of AEAT activity in this way was found in preliminary

experiments to agree with the formation of ethyl[14

C]pal-mitate as detected by TLC [25] In experiments in which

AEAT was used as a reporter enzyme to detect entry of

palmitoylcarnitine into sealed microsomal vesicles,

[14C]palmitoyl-CoA was replaced by 40 lM[14

C]palmitoyl-carnitine (1.8 lCiÆlmol)1) with or without 0.5 mMCoASH

and 1 mMdithiothreitol

Measurement of uptake ofL-[3H]carnitine into

microsomal vesicles

Assays were performed at 10°C and were commenced by

the addition of 500 lL of microsomes in HS buffer

(60–80 mgÆmL)1 protein, pre-equilibrated at 10°C) to

500 lL of pre-equilibrated HS buffer containing various

concentrations of unlabelled carnitine, 5 lCi [3H]carnitine

and 2 lCi [14C]inulin At each time-point, two 50 lL

samples were removed quickly and transferred to tubes

containing 2 mL of ice-cold HS buffer containing

polyethy-lene glycol 8000 (5%, w/v) One of each pair of tubes

additionally contained 200 lg of alamethicin to permeablise

the microsomal vesicles Both tubes were immediately

centrifuged for 60 s at 6000 g to sediment the microsomal

material The supernatants were removed by aspiration and

the walls of the tubes wiped with tissue to remove adhering

fluid The pellets were dissolved in 500 lL of Triton X-100

(10%, v/v), transferred to scintillation fluid and3H and14C measured by liquid scintillation counting The amount of [3H]carnitine within microsomal vesicles at each time-point was calculated by subtracting the 3H-associated with the alamethicin-treated pellet from the3H-associated with the untreated pellet after correcting for adhering medium, which was determined from the amount of associated [14C]inulin

Measurement of protein content This was by a bicinchoninic acid assay kit (Sigma) Statistical methods

Values are shown in figures as means of the number of separate measurements (n) ± SD Where SD bars are not shown in figures, these are within the symbol

Results Transport of palmitoylcarnitine into sealed microsomal vesicles

The experiments shown in Fig 2 were performed in the absence of (Np-O)2Pi Figure 2A confirms the previously reported high degree of latency of AEAT [5,17] in that minimal formation of ethanol-dependent product (ethyl palmitate) from [14C]palmitoyl-CoA was seen with sealed microsomes whereas permeabilization by alamethicin allowed ethyl palmitate formation at an initial rate of

1020 ± 30 pmolÆmin)1Æmg)1 When [14C]palmitoylcarnitine was provided alone, there was no appreciable formation of ethyl palmitate by sealed microsomes (Fig 2B) A similar lack of ethyl palmitate formation from palmitoylcarnitine was seen with alamethicin-permeabilized microsomes, con-firming that palmitoylcarnitine is not a substrate for AEAT (data not shown) However, when CoASH was also present (together with dithiothreitol to keep coenzyme A in the reduced form) ethyl palmitate formation from [14 C]palmi-toylcarnitine by sealed microsomes was observed at a steady

Fig 2 Radiolabelled product formation by microsomes in the absence of (Np-O) 2 P i All values are means ± SD of four independent meas-urements (A) Ethanol-dependent product formation from 40 l M [14C]palmitoyl-CoA h, sealed microsomes; j, microsomes permea-bilized by alamethicin (B) Product formation from 40 l M [ 14 C]palmitoylcarnitine by sealed microsomes s, ethanol-dependent without CoASH and dithiothreitol; j, ethanol-dependent with 0.5 m CoASH + 1 m dithiothreitol.

Trang 4

rate of 180 ± 20 pmolÆmin)1Æmg)1over 10 min (Fig 2B).

From experiments such as these, Broadway et al [12]

arrived at the conclusion that although palmitoyl-CoA

could not gain access to the interior of sealed microsomes,

both palmitoylcarnitine and CoASH could do so, thereby

becoming substrates for the coupled microsomal CAT/

AEAT system – it is reasonable to expect that diffusion

across the microsomal membrane of ethanol, the

cosub-strate for AEAT, is not rate-limiting [30]

Figure 2A also shows that ethyl palmitate formation

from [14C]palmitoyl-CoA by alamethicin-permeabilized

microsomes plateaued and then declined after 10 min As

only 10% of the available14C was in ethyl palmitate or in

ethanol-independent products (not shown) at this 10 min

time interval, extensive destruction of the product(s) and/or

of the substrate must have occurred To a lesser extent, the

same is suggested by Fig 2B where the timecourse of

product formation from palmitoylcarnitine became

nonlin-ear after only 5% of the available14C could be detected

in ethanol-dependent or -independent products Diczfalusy

et al [25] have shown that the serine esterase inhibitor

(Np-O)2Piat 250 lMenhanced AEAT activity in rat liver

microsomes by approximately fivefold This effect was

primarily explained through inhibition of carboxyesterase

ES-4, which has both ethyl esterase and thioesterase

activities We therefore reinvestigated the formation of

ethyl palmitate from [14C]palmitoyl-CoA and [14

C]palmi-toylcarnitine in the presence of 250 lM (Np-O)2Pi(Figs 3

and 4) Ethyl palmitate formation from [14C]palmitoyl-CoA

was considerably enhanced by (Np-O)2Pi in

alamethicin-permeabilized microsomes (compare Fig 2A and 3A) and

also facilitated the detection of a small but significant

amount of this conversion by sealed microsomes (Fig 3A)

However, even though 40% of the available [14

C]palmi-toyl-group now appeared in ethyl palmitate after 5 min with

permeabilized microsomes, (Np-O)2Pidid not totally

abol-ish the destruction of this product (Fig 3A) Reasonable

estimates of initial rates of ethyl palmitate formation

(AEAT activity) can be made from Fig 3A These were

480 ± 52 pmolÆmin)1Æmg)1 for sealed microsomes and 18.4 ± 1.2 nmolÆmin)1Æmg)1 for those permeabilized by alamethicin, i.e 97.5% of AEAT activity was latent, indicating that these experiments were conducted with vesicles that had a high degree of intactness It was important to establish this because palmitoyl-CoA, albeit at higher concentrations in the absence of BSA, permeabilizes rat liver microsomes [31] AEAT is inhibited by high concentrations of its fatty acyl-CoA substrate [25] Figure 3B shows that our experimental conditions employed a palmitoyl-CoA concentration (40 lM) that was not inhibitory Also in general (not shown), we observed that ethanol-independent product formation from [14C]palmitoyl-CoA or [14C]palmitoylcarnitine was hardly increased by permeabilization of the microsomes, suggesting that these unspecified products are largely made by enzymes oriented towards the cytosolic face of the ER

In the presence of 250 lM(Np-O)2Pi, rates of formation

of ethanol-dependent and -independent products from

40 lM [14C]palmitoyl-CoA or [14C]palmitoylcarnitine by sealed microsomes were consistently linear from 1 to 5 min and usually were linear from 1 to 10 min Figure 4 shows values obtained within this linear range Under these experimental conditions, rates of ethanol-dependent and -independent product formation of 548 ± 34 and

148 ± 25 pmolÆmin)1Æmg)1, respectively, were seen when the substrate was 40 lM [14C]palmitoylcarnitine with CoASH/dithiothreitol (essentially zero product formation was seen in the absence of CoASH/dithiothreitol – results not shown) CoASH/dithiothreitol had minimal effect on ethanol-dependent product formation from [14 C]palmitoyl-CoA by sealed (Fig 4) or permeabilized (not shown) microsomes When microsomes were pretreated with etom-oxir, ATP and CoASH in order to generate etomoxiryl-CoA (an irreversible inhibitor of CPT1 in microsomal fractions [19]) AEAT activity measured in alamethicin-permeabilized microsomes was not inactivated (results not

Fig 3 Radiolabelled product formation from palmitoyl-CoA by

microsomes in the presence of 250 l M (Np-O) 2 P i All values are

means ± SD of four independent measurements (A) shows

ethanol-dependent product formation from 40 l M [ 14 C]palmitoyl-CoA.

h, Sealed microsomes; j, microsomes permeabilized by alamethicin.

(B) Dependence of product formation by alamethicin-permeabilized

microsomes on the concentration of [ 14 C]palmitoyl-CoA Values are

calculated from the difference between zero and 2 min time-points j,

Ethanol-dependent products; h, ethanol-independent products.

Fig 4 Radiolabelled product formation by sealed microsomes in the presence of 250 l M (Np-O) 2 P i All values are means ± SD of four independent measurements calculated from the difference between 1 and 5 min time-points Product formation was measured from 40 l M [14C]palmitoyl-CoA or [14C]palmitoylcarnitine with additions of 0.5 m M CoASH + 1 m M dithiothreitol (DTT) as indicated In some instances, microsomes were pretreated with etomoxir to inactivate CPT 1 (Materials and methods) Open bars, ethanol-independent product formation; solid bars, ethanol-dependent product formation; cross-hatched bar, ethanol-dependent product formation by CoASH-loaded microsomes (Materials and methods).

Trang 5

shown) and there was only a small increase in overt AEAT

activity, suggesting that the pretreatment caused little

increase in leakiness of the microsomes (Fig 4) Inactivation

of CPT1by etomoxiryl-CoA totally inhibited the formation

of ethanol-dependent and -independent products from

[14C]palmitoylcarnitine This suggested that the effect of

CoASH/dithiothreitol to facilitate formation of

ethanol-dependent product from [14C]palmitoylcarnitine, in

contra-diction of [12], cannot be explained by CoASH being

transported into the ER lumen to provide a cosubstrate for

the ER luminal CAT Rather, it strongly suggested that this

product formation was due to conversion of [14

C]palmi-toylcarnitine by CPT1(either an integral component of the

ER membrane [21] or a contaminant arising from

mito-chondrial contact sites [20]) to external [14C]palmitoyl-CoA,

which is then converted into ethyl palmitate by the small

amount of AEAT activity that is overt because of

incom-plete sealing of the vesicles

Free CoASH is not detectable in rat liver microsomal

fractions [32] implying that any luminal pool of CoASH is

lost during tissue extraction and/or fractionation In order

to attempt to make CoASH available to the interior of the

microsomal vesicles, some preparations were isolated with

CoASH present (Materials and methods) After

pretreat-ment with etomoxiryl-CoA, these microsomes were still

relatively sealed, as evidenced by an overt AEAT activity of

only 972 ± 88 pmolÆmin)1Æmg)1(indicating 95% latency of

AEAT) and had complete inactivation of CPT1, as

evidenced by the lack of any ethanol-independent product

formation from [14C]palmitoylcarnitine (Fig 4) However,

[14C]palmitoylcarnitine was converted into

ethanol-depend-ent product at a rate of 939 ± 188 pmolÆmin)1Æmg)1

(Fig 4) Overall, these results support the notion that

palmitoylcarnitine can be transported to the ER lumen

where it can become a substrate for the microsomal CAT/

AEAT However, externally derived CoASH cannot play

any significant role in the CAT reaction, which must rely on

an internal, luminal pool of CoASH

Transport ofL-carnitine into sealed microsomal vesicles

Transport ofL-[3H]carnitine was studied by measurement

of uptake into microsomal vesicles at 10°C Figure 5

shows initial experiments in which 2 mM carnitine was

used Because of the time needed to separate microsomes

from the incubation medium, it was not feasible to

measure uptake at times earlier than 2 min With 2 mM

carnitine at 10°C the uptake reached  60% of the

equilibrium value at 2 min allowing only a crude minimal

estimate that the initial rate of unidirectional uptake was

at least 0.62 nmolÆmin)1Æmg)1 Mersalyl and N-ethyl

maleimide are known to inactivate the mitochondrial

CAC [33,34] Mersalyl at 0.5 mMcaused 40% inhibition

of carnitine uptake at 2 min and 5 mM mersalyl almost

abolished uptake (Fig 5) However, we found that neither

N-ethyl maleimide nor sulfobetaine (which is a competitive

inhibitor of the mitochondrial CAC [35]) at concentrations

up to 5 mM had any effect on carnitine uptake by

microsomes (results not shown)

We attempted to study the concentration dependence of

L-[3H]carnitine uptake (Fig 6) These experiments appeared

to show that the rate of uptake increased linearly with

carnitine up to 10 mM, i.e there was no indication of saturation of the process However, as indicated above, initial rates determined from the first time-point can only be regarded as crude minimum estimates of the true initial rates

of unidirectional uptake These were 0.034 ± 0.003 and 2.9 ± 0.6 nmolÆmin)1Æmg)1 at 0.1 and 10 mM carnitine, respectively In other experiments (results not shown), microsomes were preloaded with 2 mMunlabelledL -carni-tine This had no effect on the time profile of subsequently measured uptake of [3H]carnitine, suggesting that an exchange carrier identical or similar to the mitochondrial CAC was not involved

Data showing unidirectional import of L-carnitine by the purified mitochondrial CAC in a reconstituted system suggest a Vmax for this process at 10°C of  2 nmolÆ min)1Æmg)1with a Km of 0.53 mM (the rate of exchange transport was much faster) [36] Even relative to total

Fig 5 Effect of mersalyl on uptake of L -[3H]carnitine by sealed microsomes Sealed microsomes were incubated with 2 m M L-[3H]carnitine and uptake measured as described under Materials and methods Values are means ± SD of four independent experiments.

h, No mersalyl; j, 0.5 m M mersalyl; s, 5 m M mersalyl.

Fig 6 Effect of L -carnitine concentration on L -[3H]carnitine uptake

by sealed microsomes Sealed microsomes were incubated with

L -[3H]carnitine and uptake measured as described under Materials and methods Values are means ± SD of four independent observations.

L -carnitine concentrations were: h, 0.1 m M ; j, 0.25 m M ; s, 0.5 m M ;

d, 1.0 m M ; n, 2.0 m M ; m, 10 m M

Trang 6

microsomal protein we have observed comparable or higher

rates of unidirectional transport than 2 nmolÆmin)1Æmg)1

This further differentiates the microsomal process from the

mitochondrial CAC

Figure 7 shows a linear plot of [3H]carnitine uptake at

equilibrium (60 min values) vs theL-carnitine

concentra-tion The slope of this line, which represents the carnitine

space of the microsomal vesicle preparation, was

1.03 lLÆmg)1 In other experiments (not shown), we found

the internal H2O space to be 2.4 ± 0.2 lLÆmg)1 [3]

4Therefore, only 43% of the vesicles present in the

micro-somal fraction appeared to contain the capability of

L-carnitine transport

Discussion

The findings of this study provide a framework whereby,

acting in concert with the ER CAT, enzymes in the ER

lumen (e.g DGAT, ACAT or AEAT) are supplied with

their fatty acyl-CoA substrate via a fatty acylcarnitine

intermediate and the resulting freeL-carnitine product can

be disposed of (Fig 1) As AEAT activity appears to be

totally localized to the interior of the ER in cells, it,

together with the luminal CAT, provides an easily

quantifiable (via assay) and unambiguous

entry of fatty acylcarnitine into the ER lumen provided

certain experimental conditions are met, i.e., inactivation

of CPT1, minimization of interference from esterases and

provision of a source of luminal CoASH either as

described here or by delivery from liposomes [24] As far

as we are aware, this study presents the first direct

demonstration of fatty acylcarnitine transport across

microsomal membranes

After taking precautions to minimize the ambiguity

inherent in using DGAT as the reporter enzyme,

Abo-Hashema et al observed carnitine-dependent incorporation

of [14C]oleoyl-CoA into liver microsomal luminal

triacyl-glycerol to the extent of 11.58 nmolÆmg)1 over an

incubation period of 40 min at 37°C (290 pmolÆmin)1Æ

mg)1) [24] Initial rates were not determined [24] and so it is not known to what extent this product formation was limited

by esterase activity or by the necessity to involve CPT1as an additional enzyme in the system prior to the membrane transport of the fatty acylcarnitine With 40 lM[14 C]palmi-toylcarnitine, we observed formation of ethyl palmitate that was linear with time at a rate of 939 pmolÆmin)1Æmg)1at

30°C, provided microsomes were isolated previously with CoASH present (Fig 4) Activities of rat liver microsomal luminal CAT (2.7–3.6 nmolÆmin)1Æmg)1at 25°C [19]) and AEAT (18.4 nmolÆmin)1Æmg)1at 30°C; see Fig 3A) exceed this value of 939 pmolÆmin)1Æmg)1suggesting that it is likely

to be a reasonable estimate of the rate of palmitoylcarnitine transport It is of note that measurements of rat liver microsomal latent DGAT activity (0.47–1.9 nmolÆmin)1Æ

mg)1at 37°C [5,7]) are not dissimilar from our measure-ment of the rate of palmitoylcarnitine transport As we discuss below, it is highly unlikely that the CAC protein plays any role in the ER membrane At present, this microsomal transport process for fatty acylcarnitine awaits characterization in future studies which should also investi-gate whether it makes a significant contribution to the control of metabolic flux to luminal enzymes such as DGAT and ACAT

Our demonstration thatL-carnitine can move across the membrane of microsomal vesicles that have a high degree of

intactness as judged by enzyme latency is a significant finding as a key feature of the scheme in Fig 1 is that free carnitine should be able to escape from the ER after its generation by the luminal CAT The observation that microsomal carnitine transport is sensitive to mersalyl (Fig 5) suggests that the process is protein-mediated rather than being a simple diffusion process (the extreme hydro-philicity of carnitine also makes this highly unlikely) The lack of sensitivity to N-ethyl maleimide and sulf-obetaine and the apparent lack of requirement for a counter-transport partner for carnitine discriminates this microsomal process from carnitine/acylcarnitine transport

in mitochondria – findings that are not at variance with the report of Fraser & Zammit that the CAC protein is not detectable in liver microsomes [4] Our attempts at a kinetic analysis (Fig 6) could not differentiate between a carrier or

a channel that facilitates the rapid equilibrium of carnitine across the microsomal membrane In this regard, it is of note that there have been reports [37–39] of a microsomal membrane channel that permits the passage of certain small molecules, some similar to carnitine (e.g choline [39]) The microsomal isotope space for choline of 1.05 lLÆmg)1 reported by Meissner & Allen [39] is remarkably similar to the space of 1.03 lLÆmg)1 that we found for L-carnitine (Fig 7) Further studies are needed to characterize the microsomalL-carnitine process

Finally, the need for an ER luminal pool of CoASH (Fig 1) is demonstrated by this study However, questions regarding the source of this pool and how it is maintained

in vivoremain totally unanswered

Acknowledgements

We are grateful to the Medical Research Council and to the Wellcome Trust for support.

Fig 7 Content of L -[3H]carnitine by sealed microsomes at equilibrium.

Equilibrium was reached by incubation with L -[3H]carnitine for

60 min (Fig 6) Values are means ± SD of four independent

experi-ments Symbols indicating L -carnitine concentrations are the same as

those in Fig 6 except that values with 10 m M L -carnitine, which also lie

on the line, are omitted for reasons of scale An intramicrosomal space

for L -carnitine (1.03 lLÆmg)1) is obtained from the slope of the line.

Trang 7

1 McGarry, J.D & Brown, N.F (1997) The mitochondrial carnitine

palmitoyltransferase system From concept to molecular analysis.

Eur J Biochem 244, 1–14.

2 Zammit, V.A (1999) Carnitine acyltransferases: functional

signi-ficance of subcellular distribution and membrane topology Prog.

Lipid Res 38, 199–224.

3 Zammit, V.A (1999) The malonyl-CoA-long-chain acyl-CoA axis

in the maintenance of mammalian cell function Biochem J 343,

505–515.

4 Fraser, F & Zammit, V.A (1999) Submitochondrial and

sub-cellular distributions of the carnitine-acylcarnitine carrier FEBS

Lett 445, 41–44.

5 Owen, M.R., Corstorphine, C.C & Zammit, V.A (1997) Overt

and latent activities of diacylglycerol acytransferase in rat liver

microsomes: possible roles in very-low-density lipoprotein

tri-acylglycerol secretion Biochem J 323, 17–21.

6 Waterman, I.J & Zammit, V.A (2002) Activities of overt and

latent diacylglycerol acyltransferases (DGATs I and II) in liver

microsomes of ob/ob mice Int J Obes Relat Metab Disord 26,

742–743.

7 Waterman, I.J & Zammit, V.A (2002) Differential effects of

fenofibrate or simvastatin treatment of rats on hepatic microsomal

overt and latent diacylglycerol acyltransferase activities Diabetes

51, 1708–1713.

8 Gibbons, G.F., Bartlett, S.M., Sparks, C.E & Sparks, J.D (1992)

Extracellular fatty acids are not utilized directly for the synthesis of

very-low-density lipoprotein in primary cultures of rat

hepato-cytes Biochem J 287, 749–753.

9 Gibbons, G.F., Islam, K & Pease, R.J (2000) Mobilisation of

triacylglycerol stores Biochim Biophys Acta 1483, 37–57.

10 Gibbons, G.F & Wiggins, D (1994) Intracellular triacylglycerol

lipase: its role in the assembly of hepatic very-low-density

lipo-protein (VLDL) Adv Enzyme Regul 35, 179–198.

11 Yang, L.Y., Kuksis, A., Myher, J.J & Steiner, G (1995) Origin of

triacylglycerol moiety of plasma very low density lipoproteins in

the rat: structural studies J Lipid Res 36, 125–136.

12 Broadway, N.M., Gooding, J.M & Saggerson, E.D (1999)

Car-nitine acyltransferases and associated transport processes in the

endoplasmic reticulum Missing links in the VLDL story? Adv.

Exp Medical Biol 466, 59–67.

13 Joyce, C., Skinner, K., Anderson, R.A & Rudel, L.L (1999)

Acyl-coenzyme A: cholesteryl acyltransferase 2 Curr Opin Lipidol 10,

89–95.

14 Rudel, L.L., Lee, R.G & Cockman, T.L (2001) Acyl coenzyme

A: cholesterol acyltransferase types 1 and 2: structure and function

in atherosclerosis Curr Opin Lipidol 12, 121–127.

15 Buhman, K.F., Accad, M & Farese, R.V (2000) Mammalian

acyl-CoA: cholesterol acyltransferases Biochim Biophys Acta

1529, 142–154.

16 Joyce, C.W., Shelness, G.S., Davis, M.A., Lee, R.G., Skinner, K.,

Anderson, R.A & Rudel, L.L (2000) ACAT1 and ACAT2

membrane topology segregates a serine residue essential for

activity to opposite sides of the endoplasmic reticulum membrane.

Mol Biol Cell 11, 3675–3687.

17 Polokoff, M.A & Bell, R.M (1978) Limited

palmitoyl-CoA penetration into microsomal vesicles as evidenced by a

highly latent ethanol acyltransferase activity J Biol Chem 253,

7173–7178.

18 Murthy, M.S & Pande, S.V (1994) Malonyl-CoA-sensitive

and -insensitive carnitine palmitoyltransferase activities of

micro-somes are due to different proteins J Biol Chem 269, 18283–

18286.

19 Broadway, N.M & Saggerson, E.D (1995) Solubilization and

separation of two distinct carnitine acyltransferases from hepatic

microsomes: characterization of the malonyl-CoA-sensitive enzyme Biochem J 310, 989–995.

20 Broadway, N.M., Pease, R.J., Birdsey, G., Shayeghi, M., Turner, N.A & David Saggerson, E (2003) The liver isoform of carnitine palmitoyltransferase 1 is not targeted to the endoplasmic reticulum Biochem J 370, 223–231.

21 Fraser, F., Corstorphine, C.G., Price, N.T & Zammit, V.A (1999) Evidence that carnitine palmitoyltransferase I (CPT I) is expressed in microsomes and peroxisomes of rat liver Distinct immunoreactivity of the N-terminal domain of the microsomal protein FEBS Lett 446, 69–74.

22 Cohen, I., Guillerault, F., Girard, J & Prip-Buus, C (2001) The N-terminal domain of rat liver carnitine palmitoyltransferase 1 contains an internal mitochondrial import signal and residues essential for folding of its C-terminal catalytic domain J Biol Chem 276, 5403–5411.

23 Prip-Buus, C., Cohen, I., Kohl, C., Esser, V., McGarry, J.D & Girard, J (1998) Topological and functional analysis of the rat liver carnitine palmitoyltransferase 1 expressed in Saccharomyces cerevisiae FEBS Lett 429, 173–178.

24 Abo-Hashema, K.A., Cake, M.H., Power, G.W & Clarke, D (1999) Evidence for triacylglycerol synthesis in the lumen of microsomes via a lipolysis-esterification pathway involving carni-tine acyltransferases J Biol Chem 274, 35577–35582.

25 Diczfalusy, M.A., Bjorkhem, I., Einarsson, C & Alexson, S.E (1999) Formation of fatty acid ethyl esters in rat liver microsomes Evidence for a key role for acyl-CoA: ethanol O-acyltransferase Eur J Biochem 259, 404–411.

26 Jones, L.R., Maddock, S.W & Besch, H.R Jr (1980) Unmasking effect of alamethicin on the (Na+,K+) -ATPase, beta-adrenergic receptor-coupled adenylate cyclase, and cAMP-dependent protein kinase activities of cardiac sarcolemmal vesicles J Biol Chem.

255, 9971–9980.

27 Nagaraj, R & Balaram, P (1981) Alamethicin, a transmembrane channel Acc Chem Res 14, 356–362.

28 Ojcius, D.M & Young, J.D (1991) Cytolytic pore-forming pro-teins and peptides: is there a common structural motif? Trends Biochem Sci 16, 225–229.

29 Fulceri, R., Banhegyi, G., Gamberucci, A., Giunti, R., Mandl, J.

& Benedetti, A (1994) Evidence for the intraluminal positioning

of p-nitrophenol UDP-glucuronosyltransferase activity in rat liver microsomal vesicles Arch Biochem Biophys 309, 43–46.

30 Pederson, B.A., Foster, J.D & Nordlie, R.C (1998) Low-Km mannose-6-phosphatase as a criterion for microsomal integrity Biochem Cell Biol 76, 115–124.

31 Banhegyi, G., Csala, M., Mandl, J., Burchell, A., Burchell, B., Marcolongo, P., Fulceri, R & Benedetti, A (1996) Fatty acyl-CoA esters and the permeability of rat liver microsomal vesicles Biochem J 320, 343–344.

32 Garland, P.B., Shepherd, D & Yates, D.W (1965) Steady-state concentrations of coenzyme A, acetyl-coenzyme A and long-chain fatty acyl-Coenzyme A in rat-liver mitochondria oxidizing pal-mitate Biochem J 97, 587–594.

33 Pande, S.V & Parvin, R (1976) Characterization of carnitine acylcarnitine translocase system of heart mitochondria J Biol Chem 251, 6683–6691.

34 Noel, H., Goswami, T & Pande, S.V (1985) Solubilization and reconstitution of rat liver mitochondrial carnitine acylcarnitine translocase Biochemistry 24, 4504–4509.

35 Murthy, M.S & Pande, S.V (1984) Mechanism of carnitine acylcarnitine translocase-catalyzed import of acylcarnitines into mitochondria J Biol Chem 259, 9082–9089.

36 Indiveri, C., Tonazzi, A & Palmieri, F (1991) Characterization of the unidirectional transport of carnitine catalyzed by the recon-stituted carnitine carrier from rat liver mitochondria Biochim Biophys Acta 1069, 110–116.

Trang 8

37 Nilsson, R., Peterson, E & Dallner, G (1973) Permeability of

microsomal membranes isolated from rat liver J Cell Biol 56,

762–776.

38 Ballas, L.M & Arion, W.J (1977) Measurement of glucose

6-phosphate penetration into liver microsomes Confirmation of

substrate transport in the glucose-6-phosphatase system, J Biol Chem 252, 8512–8518.

39 Meissner, G & Allen, R (1981) Evidence for two types of rat liver microsomes with differing permeability to glucose and other small molecules J Biol Chem 256, 6413–6422.

Ngày đăng: 16/03/2014, 16:20

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

🧩 Sản phẩm bạn có thể quan tâm